- Home
- TZOO vs RAPT Comparison
TZOO vs RAPT Comparison
Compare TZOO & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TZOO
- RAPT
- Stock Information
- Founded
- TZOO 1998
- RAPT 2015
- Country
- TZOO United States
- RAPT United States
- Employees
- TZOO N/A
- RAPT N/A
- Industry
- TZOO Advertising
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- TZOO Consumer Discretionary
- RAPT Health Care
- Exchange
- TZOO Nasdaq
- RAPT Nasdaq
- Market Cap
- TZOO 102.8M
- RAPT 106.8M
- IPO Year
- TZOO 2002
- RAPT 2019
- Fundamental
- Price
- TZOO $11.50
- RAPT $1.83
- Analyst Decision
- TZOO Strong Buy
- RAPT Hold
- Analyst Count
- TZOO 3
- RAPT 9
- Target Price
- TZOO $21.67
- RAPT $9.25
- AVG Volume (30 Days)
- TZOO 116.5K
- RAPT 277.2K
- Earning Date
- TZOO 10-22-2024
- RAPT 08-08-2024
- Dividend Yield
- TZOO N/A
- RAPT N/A
- EPS Growth
- TZOO 43.41
- RAPT N/A
- EPS
- TZOO 0.96
- RAPT N/A
- Revenue
- TZOO $84,874,000.00
- RAPT N/A
- Revenue This Year
- TZOO $4.25
- RAPT N/A
- Revenue Next Year
- TZOO $13.66
- RAPT N/A
- P/E Ratio
- TZOO $12.38
- RAPT N/A
- Revenue Growth
- TZOO 9.96
- RAPT N/A
- 52 Week Low
- TZOO $4.77
- RAPT $1.81
- 52 Week High
- TZOO $12.59
- RAPT $27.35
- Technical
- Relative Strength Index (RSI)
- TZOO 55.97
- RAPT 29.63
- Support Level
- TZOO $10.80
- RAPT $2.12
- Resistance Level
- TZOO $12.25
- RAPT $2.38
- Average True Range (ATR)
- TZOO 0.52
- RAPT 0.18
- MACD
- TZOO -0.20
- RAPT -0.01
- Stochastic Oscillator
- TZOO 39.11
- RAPT 2.70
About TZOO Travelzoo
Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; and Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties. Most of the company's revenue is derived from North America.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.